Fetal Fibronectin Enzyme Immunoassay
Device Diagnostics
PDI 15420045505346
General payments
$212,874
Research payments
$164,869
Through program year 2025, $212,874 in general payments and $164,869 in research payments were reported against Fetal Fibronectin Enzyme Immunoassay (Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $106,973 | 545 |
| 2024 | General | $72,689 | 63 |
| 2024 | Research | $82,435 | 1 |
| 2023 | General | $13,576 | 131 |
| 2022 | General | $19,636 | 52 |
| 2022 | Research | $82,435 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
791 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.